Healy wins CERSI research award

CERSI logo

Professor Kevin Healy has been awarded a grant from the FDA through the UCSF-Stanford Center of Excellence in Regulatory Science and Innovation (CERSI). The grant will cover collaborative research on “Multi-organ microphysiological systems for modeling clinical drug effects.”

Read More

Cannabis – made by synthetic biology

Feeding yeast

Professor Jay Keasling and collaborators have engineered brewer’s yeast to produce marijuana’s main ingredients—mind-altering THC and non-psychoactive CBD—as well as novel cannabinoids not found in the plant itself. Feeding only on sugar, the yeast are an easy and cheap way to produce pure cannabinoids that today are costly to extract from the buds of the marijuana plant, Cannabis sativa.

Read More

Mofrad Lab introduces “Deep Echocardiography”

Published this week in Nature Public Journals: Digital Medicine, Professor Mohammad Mofrad’s lab introduces “Deep Echocardiography” by applying deep learning towards clinical classifications and diagnostics of cardiac diseases.

Read More

Murthy Lab tech rapidly identifies antibiotic-resistant ‘superbugs’

Tara and well plate

Prof Niren Murthy’s lab, led by postdoc Tara deBoer, has developed a new cheap and simple point-of-care assay for diagnosing bacterial drug resistance. Termed DETECT, the technology can identify bacterial drug resistance directly from patient urine samples. The study appears on the Oct. 18 cover of the journal ChemBioChem.

Read More

Arkin Lab disentangles bacterial gene translation

data visualization

Using a massive set of 244,000 synthetic sequence experiments, Adam Arkin and his collaborators disentangled some of the complex determinants for how bacterial genes are translated. Published today in Nature Biotechnology, their work has made it possible to identify general rules for optimizing protein expression, a fundamental step in understanding living systems, and takes another step toward the efficient design of engineered bacterial gene expression systems.

Read More

Building a diseased heart

healy heart model

To develop useful in vitro model systems for identifying the correlation between genetic deficiencies and environmental stress for cardiomyopathy, Professor Kevin Healy and his lab teamed up with molecular biologists at the Gladstone Institute of Cardiovascular Diseases to combine cutting edge tissue engineering and genome editing techniques to create a “diseased heart micro-tissue” model to mimic both the genetic and physical components of cardiomyopathy.

Read More